We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$345M
AUM Growth
-$28.9M
Cap. Flow
-$37.9M
Cap. Flow %
-10.97%
Top 10 Hldgs %
29.4%
Holding
780
New
93
Increased
153
Reduced
203
Closed
29

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.68%
2 Technology 13.28%
3 Healthcare 12.33%
4 Financials 8.86%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCS
301
PIMCO Strategic Income Fund
RCS
$232M
$96.3K 0.03%
15,001
-8,000
-35% -$51.4K
TSCO icon
302
Tractor Supply
TSCO
$17.2B
$95.9K 0.03%
3,345
+3,315
+11,050% +$95.3K
RPD icon
303
Rapid7
RPD
$840M
$94.2K 0.03%
1,539
-348
-18% -$20.7K
CHNG
304
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$91.7K 0.03%
+6,320
New +$80.4K
JQC icon
305
Nuveen Credit Strategies Income Fund
JQC
$687M
$91.6K 0.03%
+15,500
New +$92.8K
CNH
306
CNH Industrial
CNH
$22.5B
$90.7K 0.03%
+13,390
New +$88.8K
SSO icon
307
ProShares Ultra S&P500
SSO
$8.76B
$90.4K 0.03%
+4,920
New +$88.5K
SRPT icon
308
Sarepta Therapeutics
SRPT
$2.19B
$89.3K 0.03%
636
TEVA icon
309
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
$88.8K 0.03%
9,861
+4,606
+88% +$48.7K
AXSM icon
310
Axsome Therapeutics
AXSM
$10.7B
$88.6K 0.03%
1,243
-57
-4% -$4.44K
AQUA
311
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$88.3K 0.03%
+4,160
New +$83K
CVS icon
312
CVS Health
CVS
$121B
$87.5K 0.03%
1,499
-6,759
-82% -$421K
NUE icon
313
Nucor
NUE
$58.7B
$87.3K 0.03%
1,947
+224
+13% +$9.92K
MMSI icon
314
Merit Medical Systems
MMSI
$5.15B
$87.3K 0.03%
2,008
-188
-9% -$8.5K
FLIR
315
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$87.3K 0.03%
2,436
+2,402
+7,065% +$91.6K
HAE icon
316
Haemonetics
HAE
$4.83B
$87.2K 0.03%
+1,000
New +$87.4K
EPI icon
317
WisdomTree India Earnings Fund ETF
EPI
$1.95B
$87.1K 0.03%
3,690
-12,535
-77% -$285K
ICUI icon
318
ICU Medical
ICUI
$3.9B
$87K 0.03%
476
+458
+2,544% +$86.2K
TOL icon
319
Toll Brothers
TOL
$12.4B
$86.8K 0.03%
1,784
+1,712
+2,378% +$69.2K
RGNX icon
320
Regenxbio
RGNX
$525M
$86.5K 0.03%
3,145
+431
+16% +$14.1K
TRHC
321
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$86.3K 0.03%
+2,117
New +$105K
AEIS icon
322
Advanced Energy
AEIS
$10B
$86.3K 0.03%
+1,371
New +$95.7K
BKI
323
DELISTED
Black Knight, Inc. Common Stock
BKI
$86.2K 0.03%
+990
New +$78K
AMED
324
DELISTED
Amedisys
AMED
$86.1K 0.02%
+364
New +$82.8K
SWCH
325
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$85.6K 0.02%
+5,483
New +$93.4K

Similar funds

Exane Derivatives's Q3 2020 Portfolio in Review

As of Q3 2020, Exane Derivatives held 780 positions worth $345M, down 7.7% from $374M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Exane Derivatives withdrew a net $37.9M in Q3 2020, closing 29 positions and reducing 203 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $8.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in iShares MSCI Turkey ETF worth $10.6M.

  • Exane Derivatives's largest Q3 2020 buy was iShares MSCI Turkey ETF: 537,062 shares worth $10.6M.
  • Exane Derivatives added most to State Street Energy Select Sector SPDR ETF in Q3 2020, an estimated $15.1M increase.
  • Exane Derivatives's biggest Q3 2020 reduction was Linde, cutting an estimated $7.17M.
  • Exane Derivatives fully exited iShares MSCI Emerging Markets ETF in Q3 2020, selling an estimated $8.3M.
  • Exane Derivatives's ten largest holdings make up 29% of its $345M portfolio in Q3 2020.
  • Exane Derivatives opened 93 new positions and closed 29 in Q3 2020.
  • Exane Derivatives's portfolio value fell 7.7% quarter-over-quarter to $345M.

Based on Exane Derivatives's 13F filing for Q3 2020, filed 6 Oct 2020.